BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
19.73
-0.56 (-2.76%)
At close: Mar 9, 2026, 4:00 PM EDT
19.73
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $825.03 million as of March 9, 2026. Its market cap has increased by 423.05% in one year.
Market Cap
825.03M
Enterprise Value
524.20M
1-Year Change
423.05%
Ranking
Category
Stock Price
$19.73
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has increased from $615.01M to $825.03M, an increase of 34.15%. That is a compound annual growth rate of 22.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 847.16M | 78.59% |
| Dec 31, 2025 | 474.36M | 128.54% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harrow | 1.35B |
| Alvotech | 1.26B |
| Collegium Pharmaceutical | 1.18B |
| Evotec SE | 1.11B |
| Cronos Group | 976.99M |
| Pacira BioSciences | 890.78M |
| Amphastar Pharmaceuticals | 877.46M |
| Tilray Brands | 840.01M |